Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine for Acute Pancreatitis with Intra-abdominal Hypertension
NCT02543658Phase 2Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Sep 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of neostigmine in acute pancreatitis (AP) and Intra-abdominal hypertension (IAH), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Percent Change of Intra-abdominal Pressure After Treatment at 7 days. Started Sep 2015; status: completed.
02
Drugs
neostigmine
03
Conditions
acute pancreatitis (AP)Intra-abdominal hypertension (IAH)
Beyond the preview
Go deeper on NCT02543658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543658.